Some patients with lupus who possess specific antibodies are at a higher risk of thrombotic events such as a blood clot, stroke or heart attack, a new study led by Johns Hopkins Medicine researchers shows. The finding might help clinicians determine which patients may need early treatment and clinical monitoring for thrombotic events.